BA vs XFOR · P/E 89, rev $89.46B vs rev $6.5M
The Boeing Company (BA) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 154.2% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the BA and XFOR stock pages for the full models.
Not investment advice.